相关实验视频

Updated: Aug 17, 2026

Serum and Plasma Copy Number Detection Using Real-time PCR

Serum and Plasma Copy Number Detection Using Real-time PCR

Published on: December 15, 2017

ALYREF (Aly/REF出口因子):一种潜在的生物标志物,用于预测癌症发生率和治疗疗效

Yan Zhao¹, Cheng Xing¹, Hongling Peng²

¹Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.

|December 22, 2023

概括

结合RNA的蛋白质ALYREF促进癌症的进展和耐药性. 这次审查强调了ALYREF作为癌症治疗的潜在预后生物标志物和治疗标.

科学领域:

生物化学生物化学
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.
分子生物学分子生物学

背景情况:

5-甲基细胞氨酸 (m5C) 是一种关键的RNA表观遗传修饰.
一种RNA结合蛋白质ALYREF与恶性表型和治疗耐药性有关.
目前针对ALYREF的临床应用和药物试验有限.

研究的目的:

审查关于ALYREF在癌症发生中的作用的文献.
突出ALYREF作为预后生物标志物的重要性.
强调ALYREF作为一个潜在的治疗目标.

主要方法:

对ALYREF的功能进行文献综述.
对ALYREF在癌症进展中的参与进行分析.
审查ALYREF的监管机制.

主要成果:

异常的ALYREF表达驱动了扩散,转移和耐药性.
ALYREF影响了mRNA前处理,mRNA稳定性和核-细胞质穿.
有证据表明ALYREF在癌症预后中的作用.

结论:

艾利瑞夫是恶性表型的关键调节剂.
作为早期预防的生物标志物,ALYREF具有前景.
向ALYREF为癌症提供了一个潜在的治疗策略.

关键词:

阿里雷夫 (Alyref) 是一个名为阿里雷夫 (Alyref) 的名字.恶性疾病是恶性的.这是一种RNA结合蛋白.研究进展的研究进展.

更多相关视频

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...